Polymerase Chain Reaction (PCR) technology is being used routinely in life sciences research, clinical applications and biopharmaceutical companies for rapid and highly specific diagnosis of infectious diseases, including those caused by bacteria or viruses and biotherapeutic product development. PCR also allows early diagnosis of malignant diseases such as leukemia and lymphomas, at a higher sensitivity and specificity than many other available molecular diagnostic methods.
The global Polymerase Chain Reaction market report estimates the market size (Revenue US$ million – 2014 to 2021) and composition of this market and also forecasts growth trends (CAGR% – 2017 to 2021). The PCR market is segmented by PCR Systems or Instrument (Standard PCR Systems, Real Time PCR Systems, Digital PCR Systems), Reagents and Consumables, Applications (Clinical Diagnostics, Life Sciences), End Users (Academic and Research Organizations, Clinical Diagnostics Labs and Hospitals, Pharmaceutical and Biotechnology Industries). It also covers the major companies operating in the market and provides detailed market analysis of the different PCR systems such as standard, real-time and digital PCR machines available in the global market.
The global Polymerase Chain Reaction market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global Polymerase Chain Reaction market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.